REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update

16 Apr 2015 07:00

RNS Number : 3582K
AorTech International PLC
16 April 2015
 

AorTech International Plc ("AorTech" or the "Company")

 

Post Year End Update to Shareholders on litigation and other matters.

 

Further to the end of the Company's financial year on 31 March 2015 the Company provides the following update on its financial position, trading and litigation with its former CEO.

 

The Company confirms that it continues to pursue its legal dispute against its former CEO Frank Maguire. Mr. Maguire has made a counterclaim for alleged non-payment of expenses totalling $168,000. The Board believes that this claim is of little merit and appears to include expenses already reimbursed. The Company will continue to defend the claim vigorously. As anticipated, the Company has also brought a lawsuit against Mr. Maguire's new business interest and certain related parties. The other parties named in the Company's related action asserted counterclaims alleging abuse of legal process. Those counterclaims have been dismissed.

 

Overall, the Board does not believe that there has been any material change in the status of the litigation. As previously announced, AorTech maintains insurance in place to protect its intellectual property and the Board can confirm that 90 % of the ongoing legal costs of the disputes are covered by that insurance.

 

As set out in the interim results announcement the manufacturing license is not generating the levels of revenues that we had first hoped for however we are in continuing discussions regarding opportunities between manufacturing and product licensees that could see an improvement in this business area. There is no further update or material change to other licenses.

 

The Company's cash position at the end of March stood at $360,000, a slightly improved position than at the half year stage. The long standing debtor continues to meet its payment schedule and should be recovered as anticipated, however the $175,000 debtor mentioned at the interim stage has now grown to $275,000. A blue chip has a secondary payment obligation on this debt and the process of ensuring recovery is being considered. The Company's financial position remains reliant on the timely collection of the debtor book as set out in the interim results.

 

It is currently too early to provide guidance on full year turnover as final quarter royalties have still to be notified by licensees.

 

 

 

 

Enquiries:

 

AorTech International plc

Bill Brown, Chairman

Tel: +44 (0) 7730 718296

 

finnCap

Stuart Andrews/Giles RollsfinnCap as Nominated AdviserTel: 020 7220 0500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFFFWIFISEFL
Date   Source Headline
17th Jun 20207:00 amRNSChange of Name and Rebranding
8th Jun 20207:00 amRNSUpdate on Elective Surgery and Customer Orders
27th May 20207:00 amRNSNew Patent
20th May 20207:00 amRNSGrant Funding for Subsidiary
13th May 20207:00 amRNSTrading Update
14th Apr 202010:27 amRNSFurther Update re COVID-19
2nd Apr 20202:13 pmRNSHolding(s) in Company
1st Apr 20201:36 pmRNSDirector/PDMR Shareholding
31st Mar 202010:28 amRNSResult of General Meeting and Total Voting Rights
30th Mar 20203:37 pmRNSUpdate re Acquisition of RUA and COVID-19
25th Mar 20207:00 amRNSUpdate re Acquisition and General Meeting
11th Mar 20207:00 amRNSProposed Acquisition of RUA Medical & Name Change
21st Jan 20207:00 amRNSExtension to Agreement with RUA Medical
6th Jan 20207:00 amRNSHeart Valve Development Update
2nd Dec 20197:00 amRNSNew Share Option Scheme and Grant of Share Options
29th Nov 20197:00 amRNSHalf-year Report
27th Nov 20191:09 pmRNSNew Licence Agreement
11th Oct 20197:00 amRNSTrading Update
3rd Sep 20191:14 pmRNSHolding(s) in Company
19th Aug 20192:53 pmRNSResult of AGM
5th Aug 20191:36 pmRNSPosting of Report & Accounts and Notice of Meeting
29th Jul 201912:52 pmRNSHolding(s) in Company
17th Jul 20197:00 amRNSFinal Results
8th Jul 201911:05 amRNSSecond Price Monitoring Extn
8th Jul 201911:00 amRNSPrice Monitoring Extension
19th Jun 20197:01 amRNSChange of Adviser
19th Jun 20197:00 amRNSDirectors' Disclosures
17th Jun 201910:47 amRNSDirectors' Disclosures
14th May 20197:00 amRNSTrading Update
24th Jan 201912:36 pmRNSCompany Update
22nd Nov 20187:00 amRNSInterim Results
15th Oct 20185:34 pmRNSHolding(s) in Company
5th Sep 20187:00 amRNSHolding(s) in Company
30th Aug 201811:18 amRNSHolding(s) in Company
23rd Aug 20182:03 pmRNSResult of AGM
23rd Aug 20187:00 amRNSAGM Statement
26th Jul 20183:33 pmRNSHolding(s) in Company
25th Jul 20184:40 pmRNSSecond Price Monitoring Extn
25th Jul 20184:35 pmRNSPrice Monitoring Extension
20th Jul 20187:00 amRNSFinal Results
4th Jul 20187:00 amRNSNew Patent Issued
28th Jun 20187:00 amRNSDevelopment and Supply Agreement with RUA Medical
26th Jun 201812:49 pmRNSNew Patent Issued
19th Jun 20189:30 amRNSDevelopment Agreement Signed
15th Jun 20183:54 pmRNSHolding(s) in Company
13th Jun 201811:47 amRNSHolding(s) in Company
8th Jun 201812:02 pmRNSResult of GM and TVR
8th Jun 20187:00 amRNSResult of Open Offer
22nd May 201812:00 pmRNSPosting of Circular
21st May 20187:00 amRNSConditional Placing and Proposed Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.